Funder: National Institutes of Health
Due Dates: October 11, 2029 (Closing date for applications)
Funding Amounts: No cost sharing or matching required
Summary: Supports research on the causes, biological mechanisms, and risk identification of sporadic non-hereditary early-onset cancers in adults ages 18–49.
Key Information: Applications involving foreign subawards or subcontracts will not be considered for funding.
Description
This National Institutes of Health opportunity supports research into sporadic, non-hereditary early-onset cancers in adults ages 18–49. It seeks to explain the rise of cancers in young adults and inform prevention and control strategies. The program supports both exploratory/developmental and standard research projects through the RP1 grant mechanism. Clinical trials are optional.
Studies should address one or more of three areas: environmental or lifestyle exposures driving increased incidence, including differences by patient demographics; biological mechanisms and host responses underlying the increase; or more effective identification of people at increased risk. The emphasis is on understanding cancer etiology and mechanisms alongside strategies for identifying risk earlier.
